FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
2025-02-06
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced diseaseContinue Reading
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
2025-02-05
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
People With Lupus Are At Risk for This Type of Heart Disease
2025-01-15
WEDNESDAY, Jan. 15, 2024 (HealthDay News) — People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the arteries. Lupus patients with skin symptoms are 72% more likely to develop atherosclerotic heart disease, in which arteries become clogged and less flexible, researchers reported inContinue Reading
Gabapentin Doesn’t Increase Fall Risk, Study Suggests
2025-01-09
THURSDAY, Jan. 9, 2025 (HealthDay News) — A pain-relieving medication might be safer for seniors than first thought. A new study published Jan. 7 in the Annals of Internal Medicine says Gabapentin is widely used to help treat chronic pain and nerve pain, particularly as an alternative to opioid painkillers.Continue Reading
Early Research Points to Possible New Parkinson’s Drug
2024-12-19
THURSDAY, Dec. 19, 2024 (HealthDay News) — Parkinson’s is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the disabling neurological illness. It’s early research, still in the animal-testing stage, as explained byContinue Reading
Scientists Find Way to Deliver Medicines Across Brain’s Protective Barrier
2024-11-27
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — The blood-brain barrier is a natural membrane that protects your brain from toxins and germs. Unfortunately, this barrier also hampers the delivery of important medicines and therapies into the brain. But researchers now think they’ve figured out a way to get drugs pastContinue Reading
Breathing Dirty Air Might Raise Eczema Risks
2024-11-15
FRIDAY, Nov. 15, 2024 (HealthDay News) — Cases of the autoimmune skin condition eczema appear to rise in areas most plagued by air pollution, new research shows. Since data has long shown that rates of eczema — clinically known as atopic dermatitis — increase along with industrialization, dirty air mightContinue Reading
Costs for MS, Parkinson’s and Alzheimer’s Meds Keep Rising
2024-10-31
THURSDAY, Oct. 31, 2024 (HealthDay News) — A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson’s and Alzheimer’sContinue Reading
Antibiotics Reveal Links Between Gut Microbes, Parkinson’s
2024-10-25
FRIDAY, Oct. 24, 2024 (HealthDay News) — Certain gut microbes might be linked to a person’s risk of developing Parkinson’s disease, a new study suggests. People prescribed multiple courses of penicillin antibiotics have a modestly lower risk of developing Parkinson’s, researchers found. Those antibiotics might be affecting bacterial populations inContinue Reading
NFL Hall of Famer Brett Favre Has Parkinson’s Disease
2024-09-24
TUESDAY, Sept. 24, 2024 (HealthDay News) — Green Bay Packers legend and NFL Hall of Famer Brett Favre announced Tuesday that he has been diagnosed with Parkinson’s disease. Favre, 54, made the announcement while testifying to Congress on his potential misuse of taxpayer funds. The former quarterback has been presentingContinue Reading